David S. Weinberg, MD, MSc
Weinberg DS. Colorectal Cancer Screening. Ann Intern Med. 2008;148:ITC2-1. doi: 10.7326/0003-4819-148-3-200802050-01002
Download citation file:
Published: Ann Intern Med. 2008;148(3):ITC2-1.
Editor's Note: This issue of In the Clinic has been updated.
Colorectal cancer is the fourth most common type of cancer and the second leading cause of cancer death in the United States (1). Outside the United States, the impact of colorectal cancer is also immense. In terms of global incidence, it ranks third among cancers affecting women and fourth for men (2). Assuming no improvement in cancer control strategies, colorectal cancer prevalence rates will increase more rapidly than U.S. population growth during the years 2000 to 2020, largely because of population aging (3). Fortunately, ample evidence shows that screening for colorectal cancer with any of several available strategies significantly decreases colorectal cancer mortality. Because most colorectal cancer arises from adenomatous polyps, detection and removal of polyps can substantially decrease the incidence of this cancer. However, many people who would benefit from colorectal cancer screening do not receive it.
to gain full access to the content and tools.
Learn more about subscription options.
Register Now for a free account.
Gastroenterology/Hepatology, Hematology/Oncology, Cancer Screening/Prevention, Gastrointestinal Cancer, Colorectal Cancer.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only